awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49886531-59589F7E-954E-4F13-9D3F-476E8E13BF59
Q49886531-59589F7E-954E-4F13-9D3F-476E8E13BF59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49886531-59589F7E-954E-4F13-9D3F-476E8E13BF59
A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer.
P2860
Q49886531-59589F7E-954E-4F13-9D3F-476E8E13BF59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49886531-59589F7E-954E-4F13-9D3F-476E8E13BF59
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4b850770c6e3f33f6d82b63565c77f25b246270a
P2860
A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel.